$TXTM SA License approval coming! They will be th
Post# of 103030
With the acquisition of Cannabis Biosciences, Inc. in March 2017, the Company acquired the license to develop cannabis medicines using the patented extraction methods, which research indicates should produce a full-profile, highly-bioavailable extract without the associated psychoactive properties of THC. The Company has applied for a medical cannabis license in South Africa (DoH) and intends to commence the climate-controlled cultivation of cannabis and production of a cannabis extract for medical testing once the license is granted.